Xi Kang

1.4k total citations
36 papers, 627 citations indexed

About

Xi Kang is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xi Kang has authored 36 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xi Kang's work include Software-Defined Networks and 5G (5 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (4 papers). Xi Kang is often cited by papers focused on Software-Defined Networks and 5G (5 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (4 papers). Xi Kang collaborates with scholars based in China, United States and United Kingdom. Xi Kang's co-authors include Junjie Zhang, H. Jonathan Chao, Jie Chen, Guan Wang, Lindsey Jones, Si–Yi Chen, Xue F. Huang, Min Luo, Wei Xiong and Peilin Zheng and has published in prestigious journals such as Nature Communications, Blood and The Journal of Physical Chemistry B.

In The Last Decade

Xi Kang

29 papers receiving 621 citations

Peers

Countries citing papers authored by Xi Kang

Since Specialization

Citations

This map shows the geographic impact of Xi Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Kang more than expected).

Fields of papers citing papers by Xi Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Kang. The network helps show where Xi Kang may publish in the future.

Co-authorship network of co-authors of Xi Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Kang. A scholar is included among the top collaborators of Xi Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Kang. Xi Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Xanthoceras sorbifolium Oil Attenuates Hyperlipidemia Through Dual Modulation of Gut Microbiota and Lipid Metabolites: Mechanistic Insights from Lipidomics and 16S rRNA Sequencing 2025 ·Metabolites ·Yuan Tao, Miaomiao Yao, (unknown), Xi Kang, Feng Shi, Xuan Hu, Zhiyun Meng, Hui Gan, (unknown), Yunbo Sun, Guifang Dou, Shuchen Liu	0
2	Rapid and direct discovery of functional tumor specific neoantigens by high resolution mass spectrometry and novel algorithm prediction 2025 ·PubMed ·H. F. Tian, Guang Li, (unknown), (unknown), Yu Chen, Ting Zhu, Min Hu, (unknown), Wen Sun, Jiajia Li, S. Luo, Zhicheng Chen, Haibo Zeng, Nan Zheng, Jinyong Wang, Weijun Shen, Xi Kang	0
3	HDAC11 in ovarian granulosa cells coordinates LH in the maturation of oocytes in Tan sheep 2025 ·Acta Biochimica et Biophysica Sinica ·Jiaqi Shi, (unknown), Yaxiu Xu, Xiangyan Wang, Zhipeng Qi, (unknown), Jinghua Wang, Hongyuan Song, Hui Yang, Lü Jin, (unknown), (unknown), Xi Kang, Xinfeng Liu, Zhuming Zhang, Chao Wang	1
4	Hsa_circ_0001944 Regulates FXR/TLR4 Pathway and Ferroptosis to Alleviate Nickel Oxide Nanoparticles-Induced Collagen Formation in LX-2 Cells 2025 ·Toxics ·(unknown), Qingyang Chen, (unknown), Gege Li, Xi Kang, Jiarong Tang, Hui Wang, Sheng Li, Yingbiao Sun, Xuhong Chang	1
5	A novel in situ detection method for lithium plating thickness in pouch cell 2025 ·Physics of Fluids ·(unknown), Han‐Chieh Wu, Zhizhen Zhang, Xi Kang, Wei Li, Zetian Zhang, (unknown)	0
6	Identification of pyrimidine metabolism-based molecular subtypes and prognostic signature to predict immune landscape and guide clinical treatment in prostate cancer 2025 ·Annals of Medicine ·Yu‐Zhong Yu, Xiao Xie, (unknown), (unknown), Yongcheng Ren, Xi Kang, (unknown), Xiong Yang, Hong Chen, Xingcheng Wu, (unknown), Shan‐Chao Zhao	0
7	Synergistic upregulation of PD‑L1 in tumor cells and CD39 in tumor‑infiltrating CD8⁺ T cells leads to poor prognosis in patients with hepatocellular carcinoma 2024 ·Oncology Letters ·Xi Kang, (unknown), Shan Lin, Jing Li, Shunxiang Wang	4
8	Comprehensive phenolic profiling of Australian‐grown Progrades™Desmanthus through LC‐ESI‐QTOF‐MS² and determination of their antioxidant potential 2024 ·International Journal of Food Science & Technology ·Xi Kang, (unknown), Cundong Xie, Christopher Gardiner, (unknown), Hafiz Ansar Rasul Suleria, Frank R. Dunshea	2
9	Family‐based genetic analysis in schizophrenia by whole‐exome sequence to identify rare pathogenic variants 2024 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·(unknown), Runxu Yang, (unknown), (unknown), Hongbing Liu, (unknown), (unknown), Xi Kang, Xiufeng Xu, Yuqi Cheng	1
10	A novel mutation of CTC1 leads to telomere shortening in a chinese family with interstitial lung disease 2023 ·Hereditas ·Lv Liu, (unknown), Sheng Yue, Xi Kang, Hong Peng, Hong Luo, Liang‐Liang Fan	3
11	Tertiary lymphoid structures in gynecological cancers: prognostic role, methods for evaluating, antitumor immunity, and induction for therapy 2023 ·Frontiers in Oncology ·(unknown), Xiao Xie, (unknown), (unknown), Dan Liao, (unknown), Xi Kang, Huiping Jiang, Suiqun Guo	1
12	LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target 2021 ·Oncogene ·Xi Kang, Weilin Li, Weixin Liu, Han Liang, Jingyu Deng, Chi Chun Wong, (unknown), Wei Kang, Ka‐Fai To, Philip Wai Yan Chiu, Guiying Wang, Jun Yu, Enders K. Ng	32
13	Bi-allelic BRWD1 variants cause male infertility with asthenoteratozoospermia and likely primary ciliary dyskinesia 2021 ·Human Genetics ·Ting Guo, Chaofeng Tu, Danhui Yang, Shuizi Ding, Cheng Lei, Rongchun Wang, Lv Liu, Xi Kang, (unknown), Yifeng Yang, Zhiping Tan, Yue‐Qiu Tan, Hong Luo	26
14	Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia 2021 ·Frontiers in Genetics ·Rongchun Wang, Danhui Yang, Ting Guo, Cheng Lei, Xu Chen, Xi Kang, Qing Jie, Hong Luo	6
15	Pharmacological Activity of Eriodictyol: The Major Natural Polyphenolic Flavanone 2020 ·Evidence-based Complementary and Alternative Medicine ·(unknown), (unknown), Muhammad Rafiq, (unknown), Yang He, Yi Cai, Xi Kang, Zhaoguo Liu, Tingdong Yan	57
16	An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses 2020 ·Nature Communications ·Guan Wang, Xi Kang, (unknown), (unknown), Lindsey Jones, Jie Chen, Xue F. Huang, Si–Yi Chen	169
17	Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells 2018 ·Molecular Therapy ·Wei Xiong, Yu‐Hui Chen, Xi Kang, Zhiying Chen, Peilin Zheng, Yi‐Hsin Elsa Hsu, Joon Hee Jang, Lidong Qin, Hao Liu, Gianpietro Dotti, Dongfang Liu	109
18	Cyclooxygenase-1 and its selective inhibitors: Research progress and perspectives 2016 ·Xi Kang, (unknown), Wenjuan Cao, (unknown), (unknown)	1
19	Load balancing for multiple traffic matrices using SDN hybrid routing 2014 ·Junjie Zhang, Xi Kang, Min Luo, H. Jonathan Chao	47
20	The nuclear factor‐κB pathway down‐regulates expression of the NKG2D ligand H60a in vitro: implications for use of nuclear factor‐κB inhibitors in cancer therapy 2013 ·Immunology ·(unknown), Xi Kang, Chanae R. Hardamon, Sumit Arora, (unknown), Hui Zhang, Jennifer Ngolab, Jack D. Bui	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact